Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. - Yung,W.K.; Prados,M.D.; Yaya-Tur,R. (J Clin Oncol, 1999)